French scientists developed an antibody that beats chemo resistance in pancreatic cancer
Pancreatic cancer is highly lethal, with only about 13% of patients surviving five years after diagnosis, according to the American Cancer Society. New treatments, including the NP137 antibody developed by French researchers and used alongside other drugs, may help improve outcomes. NP137 works as an add-on therapy by blocking a key mechanism cancer cells use […]
French scientists developed an antibody that beats chemo resistance in pancreatic cancer Read More »









